The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer
Ghazaleh Pourali(Mashhad University of Medical Sciences), Amir Avan(Mashhad University of Medical Sciences), Hamidreza Ghasemirad(Shahid Sadoughi University of Medical Sciences and Health Services), Mohammadreza Nassiri(Ferdowsi University of Mashhad), Hamid Fiuji(Mashhad University of Medical Sciences), Amir Mahmoud Ahmadzade(Mashhad University of Medical Sciences), Seyed Mahdi Hassanian(Mashhad University of Medical Sciences), Mahshid Arastonejad(Virginia Commonwealth University), Roozbeh Pourali(Ferdowsi University of Mashhad), Majid Khazaei(Mashhad University of Medical Sciences), Gordon A. Ferns(Brighton and Sussex Medical School), Danial Kazemi(Isfahan University of Medical Sciences)
Cited by 18
Related Papers
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
|The Lancet Public Health|2025|186
Microbiome as a biomarker and therapeutic target in pancreatic cancer
|BMC Microbiology|2024|50
Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective
|Life Sciences|2022|42
Metabolic Pathways Regulating Colorectal Cancer: A Potential TherapeuticApproach
|Current Pharmaceutical Design|2022|23